Adocia SA (LSX:A1JTC2) Financings

Adocia SA

Financings

RaiseDateIn US dollars
New shares under shareholder loan agreement
Tranche closed: convertible
Buyers: Vester Finance (shareholder loan of up to €10 million)
Nov 6, 2026
Private placement of new ordinary shares
Announced: €3M · €2.042 a share · Vester Finance
Dealers: Vester Finance
Buyers: Olivier Soula (2% of the Company’s share capital following completion of the Capital Increase); Vester Finance (6.9% of the Company’s share capital following completion of the Capital Increase)
Insiders: All the directors of the Company, including the chief executive officer, participated in the Capital Increase
Use of proceeds: Promote BioChaperone technology to sign partnerships, develop AdoXLong platform towards clinic, and general corporate purposes
Oct 20, 2026US$3.36M
New shares
Tranche closed: raise
Buyers: Vester Finance (200,000 new shares issued over the month under the shareholder loan agreement)
Aug 24, 2026
Shareholder loan repayable in new shares
Update: up to €6M
Buyers: Vester Finance (shareholder loan of up to €6.0 million)
Use of proceeds: Extend cash runway until the beginning of Q2 2027
Apr 21, 2026US$7.05M
Private placement of new ordinary shares with share warrants attached (ABSAs)
Closed: €10M raised · €7.92 a share · Warrants at €9.11 for 42 months · Stifel Europe Securities SAS and Stifel Europe Limited Paris Branch (Stifel)
Dealers: Stifel Europe Securities SAS and Stifel Europe Limited Paris Branch (Stifel) (lead)
Buyers: CVI Investments, Inc. (subscribed the whole €10 million; 1,262,626 shares, 6.5% of capital post-offering)
Use of proceeds: About 50% for the AdoXLong platform, 30% for BioChaperone industrial-scale manufacturing, 20% for working capital
Dec 4, 2025US$11.66M

Read by 6ix AI from the company's releases